SenesTech (NASDAQ:SNES) Earns Sell Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of SenesTech (NASDAQ:SNESFree Report) in a research report report published on Friday. The brokerage issued a sell rating on the stock.

SenesTech Trading Down 7.5 %

NASDAQ SNES opened at $2.59 on Friday. The company has a debt-to-equity ratio of 0.05, a current ratio of 4.68 and a quick ratio of 3.49. The firm has a 50 day simple moving average of $2.76 and a 200-day simple moving average of $4.92. SenesTech has a one year low of $1.90 and a one year high of $45.60.

SenesTech (NASDAQ:SNESGet Free Report) last released its earnings results on Thursday, August 8th. The company reported ($3.08) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($3.20) by $0.12. The firm had revenue of $0.46 million during the quarter, compared to analyst estimates of $0.49 million. SenesTech had a negative return on equity of 168.64% and a negative net margin of 464.09%. During the same period last year, the business posted ($84.03) earnings per share. As a group, equities analysts forecast that SenesTech will post -11 earnings per share for the current year.

About SenesTech

(Get Free Report)

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.

Recommended Stories

Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.